Clinical Trials on Mild Alzheimer's Disease in Switzerland

Total 7519 results

University Hospital, Basel, Switzerland

Recruiting

Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease (CogCheck-MC)

Neurocognitive Disorders | Cognition Disorders | Mild Cognitive Impairment | Dementia Alzheimers

Switzerland
University of Bern

Completed

tES Effects on Associative Memory Performance

Healthy | Alzheimer Disease | Mild Cognitive Impairment

Switzerland
University of Bern

Terminated

Supporting Episodic Memory With Transcranial Direct Current Stimulation in Healthy Controls and Dementia Patients

Healthy | Alzheimer Disease | Mild Cognitive Impairment

Switzerland
University of Bern

Completed

Does Acoustic Stimulation During Sleep Boost Slow Wave Sleep and Memory Performance?

Healthy | Alzheimer Disease | Mild Cognitive Impairment

Switzerland
University of Bern

Recruiting

Tablet-based Cognitive Training

Dementia | Alzheimer Disease | Mild Cognitive Impairment

Switzerland
University of Zurich
Avid Radiopharmaceuticals; Swiss Federal Institute of Technology

Active, not recruiting

Imaging Tau Deposition in the Brain of Elderly Subjects (Add-Tau)

Healthy | Neurocognitive Disorders | Alzheimer Disease | Mild Cognitive Impairment

Switzerland
Andreas Monsch

Completed

Validation of the Montreal Cognitive Assessment in Patients With Mild and Major Neurocognitive Disorder (MoCA-Valid)

Alzheimer Disease | Mild Cognitive Impairment

Switzerland
University of Zurich
ETH Zurich

Terminated

Investigating the Clinical Consequences of Flutemetamol-PET-scanning

Dementia | Mild Cognitive Impairment | Alzheimer's Disease

Switzerland
Biogen

Recruiting

A Study to Learn About the Safety of BIIB080 and Whether it Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age (CELIA)

Mild Cognitive Impairment Due to Alzheimer's Disease | Alzheimer's Disease Dementia

Belgium, United States, Australia, Italy, Spain, Denmark, United Kingdom, Czechia, France, Poland, Switzerland, Germany, Canada, Japan, Finland, Netherlands, Sweden
Prof. Christoph M. Michel

Recruiting

Understanding Brain Mechanisms Involved in Autobiographical Memory

Alzheimer Disease | Mild Cognitive Impairment | Memory Loss

Switzerland
Takeda
Zinfandel Pharmaceuticals Inc.

Terminated

Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset (TOMMORROW)

Mild Cognitive Impairment Due to Alzheimer's Disease

United States, Germany, Switzerland, United Kingdom, Australia
Takeda

Terminated

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

Mild Cognitive Impairment Due to Alzheimer's Disease

United States, Australia, United Kingdom, Switzerland
HES-SO Valais-Wallis
Hilfiker Roger

Recruiting

Adapted Home-based Exercise Program "T&E" (Test-and-Exercise) in Persons With Alzheimer's Disease (HOPE Trial) (HOPE)

Alzheimer Disease, Early Onset

Switzerland
Novo Nordisk A/S

Active, not recruiting

A Research Study Looking at the Effect of Semaglutide on the Immune System and Other Biological Processes in People With Alzheimer's Disease

Alzheimers Disease

United States, Canada, Italy, Sweden, Denmark, Switzerland
University of Zurich
Psychiatric University Hospital, Zurich

Completed

Cognitive-Behavioral Treatment for Mild Alzheimer's Patients and Their Caregivers (CBTAC)

Alzheimer Disease

Switzerland
University of Lausanne Hospitals

Unknown

Dementia-specific Intervention of Advance Care Planning (ADIA)

Alzheimer Disease

Switzerland
Thomas Zilli

Recruiting

Effect of Low Dose Radiotherapy on Brain Amyloidosis in the Treatment of Alzheimer's Disease

Alzheimer Disease

Switzerland
Novartis

Completed

To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients

Alzheimer Disease

France, United Kingdom, Sweden, Switzerland
Novartis

Completed

Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.

Alzheimer Disease

France, Sweden, Switzerland, United Kingdom
Zurich University of Applied Sciences

Completed

Validation of the German Version of the Amsterdam Instrumental Activities of Daily Living Questionnaire®

Mild Cognitive Impairment | Mild Dementia

Switzerland
Novartis Pharmaceuticals
National Institute on Aging (NIA); Amgen; Banner Alzheimer's Institute

Terminated

A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (GS1)

Alzheimers Disease

United States, Belgium, United Kingdom, Germany, Australia, Canada, Spain, Finland, Switzerland, Netherlands
Nestlé

Completed

Psychophysiological Effects of Probiotic Supplementation

Mild to Moderate Levels of Stress

Switzerland
University of Zurich
Waid City Hospital, Zurich

Completed

Move for Your Mind - Pilot Trial (MFYM - P)

Mild Cognitive Impairment | Mild Dementia | Fall Prevention

Switzerland
Novartis Pharmaceuticals
Amgen; Banner Alzheimer's Institute

Terminated

A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease (GS2)

Alzheimers Disease

Spain, United States, Belgium, Italy, Germany, Australia, Israel, Taiwan, Japan, Canada, Korea, Republic of, United Kingdom, France, China, Argentina, Finland, Singapore, Portugal, Chile, Mexico, Switzerland, Netherlands, Iceland, Puerto... and more
Cytos Biotechnology AG

Completed

Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension

Mild Essential Hypertension | Moderate Essential Hypertension

Switzerland
Prof. Christoph M. Michel

Recruiting

Improvement of Memory in Mild Cognitive Impairment

Mild Cognitive Impairment

Switzerland
Eling DeBruin

Completed

Effectiveness of a Novel Exergame-Based Training Concept for Older Adults With Mild Neurocognitive Disorder

Mild Neurocognitive Disorder

Switzerland
Eling DeBruin

Completed

Feasibility of a Novel Exergame-Based Training Concept for Older Adults With Mild Neurocognitive Disorder

Mild Neurocognitive Disorder

Switzerland
Ospedale Regionale di Lugano

Recruiting

TMS Treatment of Social Cognition Skills in Mild Cognitive Impairment

Mild Cognitive Impairment

Switzerland
University of Bern

Completed

Factorial Trial Investigating Outcome and Adherence Relevant Factors in an Online Self-help Intervention for Depression (HERMES)

Depression Moderate | Depression Mild

Switzerland
University Hospital Inselspital, Berne
University of Bern

Completed

Virtual Reality Stimulation to Enhance Cognitive Function of Intensive Care Unit Patients

Quality of Life | Cognitive Impairment, Mild

Switzerland
School of Health Sciences Geneva
University Hospital, Geneva; University of Lausanne Hospitals; University of...

Completed

Countervail Cognitive and Cerebral Decline in Mild Cognitive Impairment Patients Using Non-medical Interventions (COPE)

Mild Cognitive Impairment

Switzerland
University Hospital, Basel, Switzerland

Completed

Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCI

Mild Cognitive Impairment

Switzerland
University of Zurich
Waid City Hospital, Zurich

Completed

Dignity Therapy for Patients With Early Dementia and Their Family (DTD)

Depressive Disorder | Dementia, Mild

Switzerland
Nestlé

Completed

Pre/Term Milk Profiling

Preterm Milk | Term Milk

Switzerland
University of Bern
University of Zurich

Completed

Real-time fMRI Neurofeedback in Patients With MCI

Mild Cognitive Impairment

Switzerland
Novo Nordisk A/S

Active, not recruiting

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

Early Alzheimer's Disease

Canada, United States, Spain, Netherlands, United Kingdom, Korea, Republic of, Portugal, Italy, Australia, Argentina, Hungary, Germany, Brazil, Poland, Denmark, Czechia, Ireland, Norway, Japan, Romania, South Africa, Sweden, Mexico, F... and more
University of Edinburgh
Innovative Medicines Initiative

Terminated

European Prevention of Alzheimer's Dementia (EPAD) Longitudinal Cohort Study (LCS) (EPAD-LCS)

Alzheimer's Dementia

United Kingdom, Belgium, France, Greece, Italy, Netherlands, Spain, Sweden, Switzerland
Novartis Pharmaceuticals

Completed

Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients

Alzheimer's Disease

Belgium, Switzerland, Spain, United States, Italy, Sweden, Canada, Germany, Norway, Netherlands
Istituto Nazionale di Ricovero e Cura per Anziani
European Union

Recruiting

engAGE: Managing cognitivE decliNe throuGh Theatre Therapy, Artificial Intelligence and Social Robots drivEn Interventions (engAGE)

Mild Cognitive Impairment | Older Adults

Italy, Norway, Switzerland
Empa, Swiss Federal Laboratories for Materials...
ETH Zurich; Geriatrische Klinik St. Gallen

Unknown

Non-invasive, Wearable Multi-parameter System for the Early Prediction of Cognitive Decline and Dementia in Older Adults

Healthy Aging | Mild Cognitive Impairment

Switzerland
Bellus Health Inc

Unknown

European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients

Alzheimer's Disease

Poland, France, Spain, Switzerland, Netherlands, Italy, Germany, Sweden, United Kingdom, Belgium
Novo Nordisk A/S

Active, not recruiting

A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)

Early Alzheimer´s Disease

Canada, United States, Taiwan, Netherlands, United Kingdom, Spain, Austria, Korea, Republic of, Portugal, Italy, Australia, Argentina, Hungary, Germany, Brazil, China, Poland, Denmark, Czechia, Ireland, Japan, South Africa, Romania, S... and more
Pediatric Clinical Research Platform

Recruiting

t-BIOMAP : Prospective Paediatric Cohort Study of Blood Biomarkers in mTBI (t-BIOMAP)

Mild Traumatic Brain Injury

Switzerland
University Hospital, Grenoble

Completed

Metacognition in Semantic Dementia: Comparison With Alzheimer's Disease (META-DEM)

Healthy | Alzheimer Disease | Semantic Dementia

France, Switzerland
University of Bern

Completed

Long-term Tablet-computer Based Casual Puzzle Video Game Intervention in Healthy Older and Cognitively Impaired Persons

Healthy | Cognitive Impairment | Mild Cognitive Impairment | Acquired Brain Injury

Switzerland
Pfizer

Terminated

Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil

Alzheimer's Disease

United States, Spain, Canada, United Kingdom, Germany, Chile, France
University Hospital, Basel, Switzerland
AbbVie; Parkinson Schweiz; Bangerter-Rhyner Foundation

Completed

Training of Psychosocial Skills Based on Cognitive Behavioural Therapy for Patients With Parkinson's Disease (CBT)

Parkinson's Disease | Mild Cognitive Impairment

Switzerland
Hoffmann-La Roche

Terminated

A Study to Evaluate the Safety and Tolerability of Long-term Administration of Gantenerumab in Participants With Alzheimer's Disease (AD)

Alzheimer Disease

United States, Korea, Republic of, Canada, Poland, Argentina, Australia, Italy, Japan, Netherlands, Spain, Switzerland, Turkey, Chile, Mexico, United Kingdom, Denmark, Russian Federation
Pfizer

Terminated

A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease Patients

Alzheimer Disease

Australia, France, Finland, Portugal, Spain, United Kingdom, Poland, Japan, Italy, Belgium, Switzerland, Netherlands, Chile, Slovakia, Sweden, New Zealand, South Africa

Clinical Trials on Mild Alzheimer's Disease in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations